David Charles Baker serves as Executive at Vallon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, David Charles Baker has executed 2 insider transactions totaling $8.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 12, 2021 involved transacting 7,843 shares valued at $50.2K.
David Charles Baker currently holds 7,843 shares of Vallon Pharmaceuticals, Inc. (VLON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Charles Baker has been a net buyer of VLON stock. They have purchased $8.0K and sold $0 worth of shares.
David Charles Baker's most recent insider trade was on Feb 12, 2021, when they sold 7,843 shares at $6.40 per share.
Get notified when new Form 4 filings are submitted
| $8.00 |
| Discretionary |